MOCHA

Commercial feasibility of triggered liposomal drug delivery by means of MOdulated CHAnnels

 Coordinatore RIJKSUNIVERSITEIT GRONINGEN 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Netherlands [NL]
 Totale costo 157˙420 €
 EC contributo 146˙433 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2011-PoC
 Funding Scheme CSA-SA(POC)
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-06-01   -   2013-05-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    RIJKSUNIVERSITEIT GRONINGEN

 Organization address address: Broerstraat 5
city: GRONINGEN
postcode: 9712CP

contact info
Titolo: Dr.
Nome: Dick
Cognome: Veldhuis
Email: send email
Telefono: +31 50 363 4142
Fax: +31 50 363 4500

NL (GRONINGEN) hostInstitution 146˙433.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

poc    limited    sound    liposomal    plan    business    release    drug    site    clinical    erc    market    liposomes   

 Obiettivo del progetto (Objective)

'The clinical use of most conventional therapies is limited either by insufficient therapeutic drug concentrations at the target tissue or the severe toxic effects of the drug on healthy tissues. The encapsulation of the drug into a liposome as a carrier and its selective delivery to the affected area is one of the solutions. Several liposomal drug formulations have been approved as anticancer therapeutics however, their clinical significance has been limited by slow passive release of the drug at the target site. The idea of ERC-PoC project is to incorporate an engineered ion channel into liposomes as a sensory valve for triggered release of the liposomal content at the target site. The unique advantage of this system is the ability to make liposomes responsive towards a signal with a sensitivity that is not possible to reach with current available systems. This makes the channels excellent candidates for use in drug carriers such as liposomes and exosomes for stimulus-induced drug release. This IP protected technology (two patents) has shown its technological feasibility in the ERC project. Within the ERC-PoC project we want to explore how we are able to enter the market by developing a sound business plan, IPR strategy, market assessment and a product development plan. The outcomes will be consolidated in a sound business plan that will be presented to venture capitalists or other strategic partners.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

ECHR (2009)

Strengthening the European Court of Human Rights: More Accountability Through Better Legal Reasoning

Read More  

ANTINEUTRINONOVA (2012)

Probing Fundamental Physics with Antineutrinos at the NOvA Experiment

Read More  

2DNANOCAPS (2011)

Next Generation of 2D-Nanomaterials: Enabling Supercapacitor Development

Read More